error
Divisa

THE DELIVERY OF REGENERATIVE MEDICINES AND THEIR IMPACT ON HEALTHCARE

,
9781439836064 ::  THE DELIVERY OF REGENERATIVE MEDICINES AND THEIR IMPACT ON HEALTHCARE
ISBN:

9781439836064

EditorialTAYLOR & FRANCIS GROUP
Edicion:
Páginas:400
Idioma:INGLES
P.V.P.: 200,88 € + 4% IVA = 208,92 €
Dto 5% Ahorras 10,45 €
Importe final iva incl. 198,47 €
PLAZO DE ENTREGA 20 DIAS

<P>NOW THAT PROHIBITIONS AGAINST STEM CELL RESEARCH ARE RELAXING, IT IS TIME FOR THE FIELD TO MOVE FORWARD WITH THE ADVANCES THAT PROMISE TO ELIMINATE SO MUCH HUMAN SUFFERING. HOWEVER, IT WOULD BE NAÏVE TO IGNORE THE FACT THAT REGENERATIVE MEDICINES POSE A WHOLE NEW SET OF CHALLENGES TO AN INDUSTRY SECTOR THAT FOR DECADES HAS GEARED ITSELF TO THE DEVELOPMENT AND DELIVERY OF TRADITIONAL PHARMACEUTICALS. </P><P>STILL, SIGNIFICANT STRIDES ARE BEING MADE. UNIQUE IN ITS FOCUS, <EM><STRONG>THE DELIVERY OF REGENERATIVE MEDICINES AND THEIR IMPACT ON HEALTHCARE</STRONG></EM> DELVES INTO MATERIAL NOT INCLUDED IN OTHER BOOKS. EDITED BY DR. CATHERINE PRESCOTT AND PROFESSOR DAME JULIA POLAK, TWO OF THE MOST RESPECTED AUTHORITIES IN STEM CELL RESEARCH AND THE BUSINESS OF REGENERATIVE MEDICINE, THIS TEXT PRESENTS ORIGINAL FIRSTHAND ACCOUNTS OF EXPERTS FROM AROUND THE GLOBE. PROFESSOR POLAK STARTS BY SUMMARIZING THE PROGRESS MADE AND THE CHALLENGES CURRENTLY FACING THE FIELD BOTH AS A SCIENCE AND AN EMERGING INDUSTRY. THIS IS FOLLOWED BY TOPICS RELEVANT TO REGULATORS, INSURERS, AND INVESTORS AS WELL AS PHARMACEUTICAL AND BIOTECH RESEARCHERS. OFFERING INNOVATIVE INSIGHT ON TOPICS RARELY COVERED, THIS VOLUME: </P><UL><P><LI>DETAILS VARIOUS INNOVATIVE INVESTMENT MODELS</LI><LI>OFFERS A DETAILED OVERVIEW OF CELL-BASED PRODUCTS AND THERAPEUTIC STEM CELL TECHNOLOGIES </LI><LI>EXAMINES CONCERNS OVER SAFEGUARDING INTELLECTUAL PROPERTY</LI><LI>LOOKS AT EVOLVING REGULATIONS IN THE U.S. AND EUROPE</LI><LI>DISCUSSES INSURANCE AND RISK MANAGEMENT AND THE ESTABLISHMENT OF REIMBURSEMENT PARAMETERS</LI><P></P></UL><P></P><P>THIS BOOK REACHES OUT TO INFORM A WIDE AUDIENCE ACROSS GOVERNMENT, INDUSTRY, AND ACADEMIA. IT GOES BEYOND THE USUAL DISCUSSIONS TO HELP INVIGORATE THE DIALOGUE AND PRESENT SOLUTIONS THAT MUST OCCUR AT THE CROSSROADS OF TECHNOLOGY AND COMMERCE FOR REGENERATIVE MEDICINES TO REALIZE THEIR PROMISE.</P>

<P><STRONG>INTRODUCTION<BR></STRONG>WHAT IS REGENERATIVE MEDICINE? <EM>J. POLAK</EM><BR><BR><STRONG>FINANCE</STRONG><BR>A NEW POLITICAL-FINANCIAL PARADIGM, <EM>R. KLEIN AND A. TROUNSON<BR></EM>INVESTMENT MODELS 4. PUBLIC FUNDING IN AUSTRALIA, <EM>G. MACDONALD<BR></EM>CAPITALISING ON A 50-YEAR LEGACY, <EM>A. LYALL</EM> <BR>INVESTING IN REGENERATIVE MEDICINE: WHAT DRIVES THE PRIVATE INVESTOR? <EM>C. PRESCOTT</EM> <BR>PUBLIC INVESTMENT MODELS: COMING OUT OF THE CLOSET AND GOING PUBLIC! <EM>R. BENJAMIN<BR><BR></EM><STRONG>BUSINESS MODELS<BR></STRONG>CELL-BASED PRODUCTS: ALLOGENIC, <EM>P. KEMP<BR></EM>AUTOLOGOUS CELL BASED PRODUCTS: FULFILLING THE PROMISE OF CELL THERAPY, <EM>E. BRAVO AND M. BLANCO-MOLINA<BR></EM>BUSINESS MODELS FOR CORD BLOOD, <EM>S. WATT<BR></EM>CHANGING THE GAME OF DRUG DISCOVERY, <EM>J. WALKER<BR></EM>DISCOVERY OF SMALL MOLECULE REGENERATIVE DRUGS, <EM>Y. CHOO</EM> <BR>THE ADOPTION OF THERAPEUTIC STEM CELL TECHNOLOGIES BY LARGE PHARMACEUTICAL COMPANIES, <EM>A. VERTES<BR></EM>ROLE OF TOOLS AND TECHNOLOGIES COMPANIES IN THE SUCCESSFUL COMMERCIALIZATION OF REGENERATIVE MEDICINE, <EM>J. GOSWAMI<BR></EM>KEY CONSIDERATIONS IN MANUFACTURING OF CELLULAR THERAPIES, <EM>R. PRETI<BR></EM>STATE OF THE GLOBAL REGENERATIVE MEDICINE INDUSTRY, <EM>L. BUCKLER, R. MARGOLIN, AND S. HAECKER<BR><BR></EM><STRONG>INTELLECTUAL PROPERTY</STRONG><BR>REGENERATING IP: EUROPE AFTER WARF, <EM>J. HITCHCOCK AND D. CREASE<BR></EM>PROTECTING REGENERATIVE MEDICINE INTELLECTUAL PROPERY IN THE USE: PROBLEMS AND STRATEGIES, <EM>D. RESNICK, R. EISENSTEIN, AND J. MCWILLIAMS<BR></EM>IMPACT OF INDIAN POLICIES AND LAWS ON REGENERATIVE MEDICINE PATENT APPLICATIONS, P<EM>. GANGULI<BR><BR></EM><STRONG>THE REGULATORY LANDSCAPE<BR></STRONG>A CATALYST FOR CHANGE: REGULATING REGENERATIVE MEDICINES IN EUROPE, <EM>C. BRAVERY<BR></EM>THE US REGULATORY REIMBURSEMENT, POLITICAL ENVIRONMENT AND STRATEGIES FOR REFORM, <EM>M. WERNER<BR></EM><BR><STRONG>REIMBURSEMENT<BR></STRONG>THE FOURTH HURDLE: REIMBURSEMENT STRATEGIES FOR REGENERATIVE MEDICINE, <EM>F. MEURGEY AND MICHELINE<BR></EM>CELLULAR THERAPIES AND REGENERATIVE MEDICINE: PREPARING FOR REIMBURSEMENT IN THE UNITED STATES, <EM>E. FAULKNER</EM> <BR>THE ADOPTION AND EVALUATION OF REGENERATIVE MEDICINE AND THE NHS, <EM>M. PARTON<BR><BR></EM><STRONG>INSURANCE</STRONG><BR>IF YOU BUILD IT WILL THEY INSURE IT? <EM>M. CLARK</EM></P>

BIOLOGIA CELULAR
FARMACOLOGIA
Libros relacionados
ISBN: 9781493991723 GENE PREDICTIONGENE PREDICTION
9781493991723
Abril 2019

159.99€ S/I
151,99€ S/I

ISBN: 9783030019914 ADVANCES IN HEART VALVE BIOMECHANICSADVANCES IN HEART VALVE BIOMECHANICS
9783030019914
Abril 2019

199.99€ S/I
189,99€ S/I

ISBN: 9788132239390 REACTIVE OXYGEN SPECIES IN PLANT BIOLOGYREACTIVE OXYGEN SPECIES IN PLANT BIOLOGY
9788132239390
Abril 2019

149.99€ S/I
142,49€ S/I

ISBN: 9780128163597 UBIQUITIN AND UBIQUITIN-LIKE PROTEIN MODIFIERSUBIQUITIN AND UBIQUITIN-LIKE PROTEIN ...
9780128163597
Marzo 2019

142€ S/I
134,90€ S/I

ISBN: 9780128180242 MOLECULAR BIOLOGY TECHNIQUESMOLECULAR BIOLOGY TECHNIQUES
9780128180242
Marzo 2019

99.95€ S/I
94,95€ S/I